FindTrial
Sign In

Phase-IIa study of AJA777 in patients with functional dyspepsia

Phase-IIa study of AJA777 in patients with functional dyspepsia

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221048
Enrollment
Unknown
Registered
2010-03-29
Start date
2010-03-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia (recruited according to the ROME III criteria)

Interventions

investigational material(s) Generic name etc : AJA777 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investiga

Sponsors

Ajinomoto Pharmaceuticals Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient showing at least one of the following 4 symptoms from more than 24 weeks before enrollment. One or more of: - postprandial fullness - early satiation - upper abdominal pain - upper abdominal discomfort

Exclusion criteria

Exclusion criteria: Patient showing symptoms of organic disease when upper gastrointestinal endoscopy is parfomed during baseline period.

Design outcomes

Primary

MeasureTime frame
Elimination rate for each individual symptom—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026